ivabradine has been researched along with Heart Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bollen Pinto, B; Chen, A; Dunaiceva, J; Elia, N; Rudiger, A; Walder, B | 1 |
| Bonadei, I; Carubelli, V; D'Aloia, A; Lombardi, CM; Metra, M; Sciatti, E; Vizzardi, E | 1 |
| Su, JB | 1 |
| Cerbai, E; Mugelli, A; Romanelli, MN; Sartiani, L | 1 |
| Lüscher, TF | 1 |
| Khawaja, MZ; Walker, DM | 1 |
| Baczkó, I; Cerbai, E; Gy Papp, J; Jaeger, K; Koncz, I; Romanelli, MN; Szél, T; Varró, A | 1 |
| Acet, A; Colak, MC; Kose, E; Parlakpinar, H; Polat, A; Samdanci, E; Sarihan, E; Tasdemir, S | 1 |
| Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
4 review(s) available for ivabradine and Heart Diseases
| Article | Year |
|---|---|
Effect of ivabradine on major adverse cardiovascular events and mortality in critically ill patients: a systematic review and meta-analyses of randomised controlled trials with trial sequential analyses.
Topics: Cardiovascular Agents; Critical Illness; Heart Diseases; Humans; Ivabradine; Treatment Outcome | 2020 |
Is there a role for ivabradine beyond its conventional use?
Topics: Anti-Arrhythmia Agents; Benzazepines; Heart Diseases; Humans; Ivabradine; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2014 |
Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Calcium Channel Blockers; Cardiotonic Agents; Cyclic Nucleotide-Gated Cation Channels; Heart Diseases; Heart Rate; Humans; Ivabradine | 2014 |
Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology.
Topics: Animals; Benzazepines; Heart Diseases; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Mutation; Myocytes, Cardiac | 2015 |
5 other study(ies) available for ivabradine and Heart Diseases
| Article | Year |
|---|---|
Supraventricular and ventricular arrhythmias.
Topics: Anticoagulants; Arrhythmogenic Right Ventricular Dysplasia; Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Heart Diseases; Hemorrhage; Humans; Ivabradine; Point-of-Care Systems | 2015 |
Ivabradine - the beauty of a slow heart rate.
Topics: Anti-Arrhythmia Agents; Benzazepines; Heart Diseases; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic | 2009 |
Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
Topics: Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Heart Diseases; Heart Rate; Humans; Ivabradine; Protein Isoforms; Sinoatrial Node | 2011 |
Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat.
Topics: Animals; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Benzazepines; Blood Pressure; Cardiotonic Agents; Catalase; Creatine Kinase; Doxorubicin; Female; Glutathione Peroxidase; Heart; Heart Diseases; Heart Rate; Ivabradine; L-Lactate Dehydrogenase; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |